intellispace portal dx/hx/ex, intellispace portal ix, and intellispace portal lx spect 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Philips Healthcare 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-08-07
  • 사례 출판 날짜
    2014-08-07
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: philips healthcare intellispace portal dx/hx/ex, intellispace portal ix, and intellispace portal lx spect medical device manufacturer, philips healthcare, has issued a field safety notice (fsn) concerning its intellispace portal dx/hx/ex, intellispace portal ix, and intellispace portal lx spect (software versions: 5 and 6). the affected software versions include 5.0.0, 5.0.1, 5.0.2, 6.0.0, 6.0.1 and 6.0.2. there are four problems mentioned in the fsn: problem 1: when reopening a bookmark generated from processing a muga (multi-gated acquisition) scan within the nm cardiac application, the ejection fraction (ef) displayed should be the same as the ef originally displayed when the bookmark was first created. in some instances, the ef may be different. there is a risk of the patient receiving an incorrect treatment plan. problem 2: when processing using one of the following nm clinical applications: auto quant, emory cardiac toolbox, corridor4dm, or neuroq, the patient study presented to the reviewing physician within the application may be for a different patient than the one selected from the patient directory. there is risk of the patient receiving an incorrect treatment plan due to misdiagnosis. problem 3: while using the nm viewer application, an arrow annotation added to a display moves away from its original position if the viewer is subsequently maximized or if the image within the viewer is subsequently zoomed in or out. incorrect area indicator annotation results in an erroneous final nuclear medicine report, which may cause subsequent mistreatment. problem 4: while displaying pet images within ct viewer, the suv results displayed may be calculated with an suv method different from the one specified in system preferences. there is a risk of misdiagnosis if suv calculation method applied is not the method selected by the user. the manufacturer will install updated software versions 5.0.2.3 and 6.0.2.3 to correct the issue. service engineer will contact the customer for implementation of the software update on the affected systems. until the site’s software is updated, the manufacturer advises users to perform the workarounds mentioned in the fsn based upon the above problem descriptions. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the products, please contact your supplier for necessary actions. posted on 7 aug 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Philips Healthcare IntelliSpace Portal DX/HX/EX, IntelliSpace Portal IX, and IntelliSpace Portal LX SPECT
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH